EBON vs CME
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 22, 2026
EBON
CME
Investment Advisor Scores
CME
AI Analyst Insights
Detailed Metrics Comparison
| Metric | EBON | CME | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 21.7865 | Tie |
| PEG Ratio | 0 | 4.68 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 9.5% | 0.8% | EBON |
| Earnings Growth | 0.0% | 2.5% | CME |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 38.9/100 | 37.7/100 | EBON |
| Profit Margin | -181.5% | 63.4% | CME |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | SELL | EBON |
Relative Price Performance (Last 90 Days)
Current Technical Phase
EBON
NeutralMixed signals - no dominant trend phase, RSI 65
CME
NeutralMixed signals - no dominant trend phase, RSI 65
Fundamentals Snapshot
| Metric | EBON | CME |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 21.3 |
| Trailing P/E | — | 22.6 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.3% | 1.0% |
| Operating Margin | -2.6% | 0.7% |
| EPS | -2.08 | 11.97 |
| Dividend Yield | — | 0.02% |